BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9296908)

  • 1. [Genetic significance of determined oxidation of drugs and xenobiotics in the pathogenesis of neoplastic diseases].
    Niewiński P; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 1997 Jan; 2(7):71-5. PubMed ID: 9296908
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of genetically determined oxidation of drugs and xenobiotics in pathogenesis of neoplastic diseases].
    Niewiński P; Orzechowska-Juzwenko K
    Postepy Hig Med Dosw; 1996; 50(4):321-32. PubMed ID: 9019742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of genetically determined acetylation of drugs and xenobiotics in pathogenesis of neoplastic diseases].
    Niewiński P; Orzechowska-Juzwenko K
    Postepy Hig Med Dosw; 1996; 50(2):131-43. PubMed ID: 8848422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver and metabolism of drugs].
    Darnis F
    Cah Med; 1974 Oct; 15(10):637-43. PubMed ID: 4455367
    [No Abstract]   [Full Text] [Related]  

  • 5. [Importance of the metabolic oxidation of drugs and other xenobiotics: recent developments].
    Fleury MB
    Ann Pharm Fr; 2011 Jan; 69(1):1-2. PubMed ID: 21296211
    [No Abstract]   [Full Text] [Related]  

  • 6. Categorization of lipophilic xenobiotics by the enthalpic structure-function response of hepatic mixed-function oxidase.
    Hollebone BR
    Drug Metab Rev; 1986; 17(1-2):93-143. PubMed ID: 3536381
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytochromes P450, drugs, and diseases.
    Guengerich FP
    Mol Interv; 2003 Jun; 3(4):194-204. PubMed ID: 14993447
    [No Abstract]   [Full Text] [Related]  

  • 8. Endogenous growth hormone and the regulation of hepatic drug oxidation in the male rat.
    Virgo BB
    Prog Clin Biol Res; 1983; 135():379-82. PubMed ID: 6141572
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inhibition of the antioxidant protection, microsomal oxidation, and xenobiotic glucuroconjugation in rats with cholestasis and their regulation].
    Bushma MI; Legon'kova LF; Zverinskiĭ IV; Khomich TI; Karpovich VE; Konovalenko OV; Karaedova LM; Lashak LK
    Biull Eksp Biol Med; 1999 Feb; 127(2):194-7. PubMed ID: 10095954
    [No Abstract]   [Full Text] [Related]  

  • 10. [What do we know about the drug metabolism?].
    Pelkonen O; Raunio H
    Duodecim; 1998; 114(10):971-7. PubMed ID: 11524785
    [No Abstract]   [Full Text] [Related]  

  • 11. [Individual variations in the oxidative metabolism of drugs. Significance of monogenic polymorphism].
    Brøsen K
    Ugeskr Laeger; 1984 Mar; 146(13):955-9. PubMed ID: 6719598
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytochrome P450-dependent oxidation and glutathione conjugation of xenobiotics in alloxan-induced diabetic rat.
    Gupta RR; Agrawal CG; Shukla GS; Ali B
    Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):231-6. PubMed ID: 9467831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Catabolism of drugs through oxidation].
    Staudinger H; Degkwitz E; Ullrich V
    Med Welt; 1969 Dec; 51():2747-54. PubMed ID: 5371539
    [No Abstract]   [Full Text] [Related]  

  • 14. [Liver metabolism of drugs].
    Polonovski J; Etienne J
    Therapie; 1969; 24(1):7-25. PubMed ID: 4390322
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advances in the study of aldehyde oxidases].
    Mi JQ; Li Y
    Yao Xue Xue Bao; 2014 May; 49(5):582-9. PubMed ID: 25151725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions.
    Bohan A; Boyer JL
    Semin Liver Dis; 2002; 22(2):123-36. PubMed ID: 12016544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacologic and toxicologic results in genetic polymorphisms (review)].
    Kohút A; Kalina I
    Cesk Fysiol; 1998 Dec; 47(4):172-84. PubMed ID: 10535175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolism of drugs. II. The factors influencing metabolic reactions].
    Dyderski S; Grzymisławski M
    Pol Merkur Lekarski; 2005 Apr; 18(106):453-6. PubMed ID: 16161933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic polymorphisms of oxidation and acetylation in cancers of digestive system].
    Barańska M; Skretkowicz J
    Pol Merkur Lekarski; 2009 Feb; 26(152):145-7. PubMed ID: 19388522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of drug metabolism--implications for drug interaction].
    Sitkiewicz D
    Pol Merkur Lekarski; 2000 Sep; 9(51):595-7. PubMed ID: 11126981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.